Intervention
Norepinephrine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 29 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
29 shownDopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)NCT07322133 · 2026-10-30
RECRUITINGEffect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro StudyNCT06285396 · 2024-03-18
RECRUITINGSex Disparities in Hypoxic Vasodilation and Impact of ObesityNCT05219799 · 2023-03-14
RECRUITINGEffects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro StudyNCT04053478 · 2019-07-08
RECRUITINGVasoactive Drugs in Intensive Care UnitNCT02118467 · 2014-05-15
RECRUITINGEffect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,NCT07614438 · 2026-08-01
NOT_YET_RECRUITINGVasopressor Agents in Pulmonary Hypertension CrisisNCT07667829 · 2026-06-01
NOT_YET_RECRUITINGNorepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean SectionNCT06574555 · 2025-04-01
COMPLETEDProphylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With PreeclampsiaNCT05035498 · 2024-02-01
UNKNOWNThe Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock PatientsNCT05886192 · 2023-05-01
UNKNOWNEvaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal CirculationNCT05568160 · 2023-01-02
ACTIVE_NOT_RECRUITINGThe Potency of Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia HypotensionNCT05035472 · 2023-01-01
UNKNOWNMaternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe PreeclampsiaNCT05035485 · 2022-09-13
COMPLETEDHypotension in the Weaning From Vasopressor DrugsNCT05506319 · 2022-05-01
COMPLETEDNorepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.NCT04556370 · 2021-11-16
COMPLETEDNorepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With PreeclampsiaNCT04556357 · 2020-09-22
COMPLETEDBlood PREssure Augmentation in Large-vessel Occlusion Stroke StudyNCT04218773 · 2020-09-11
SUSPENDEDVasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac SurgeryNCT03483753 · 2019-01-01
WITHDRAWNEffects of Vasopressors on Immune ResponseNCT02675868 · 2016-01-01
COMPLETEDNOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic ShockNCT02454348 · 2015-11-01
WITHDRAWNEffect of Different Strategies for Titrating a High MAP on MicrocirculationNCT02085291 · 2014-03-01
COMPLETEDExploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving RadiotherapyNCT01544504 · 2012-03-01
WITHDRAWNVasopressin Versus Norepinephrine for the Management of Shock After Cardiac SurgeryNCT01505231 · 2012-01-01
UNKNOWNDiscontinuation Order of Vasopressors in Septic ShockNCT01493102 · 2011-12-01
TERMINATEDExploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer PatientsNCT01263366 · 2011-01-01
TERMINATEDCaveolin-1 and Vascular DysfunctionNCT01426529 · 2010-10-01
ACTIVE_NOT_RECRUITINGContinuous Infusion of Terlipressin in Septic ShockNCT00481572 · 2007-01-01
COMPLETEDVascular Dysfunction in Diabetes: Genes and HormonesNCT01511042 · 1999-12-01
TERMINATEDGenetic Mechanisms in Human HypertensionNCT01456208 · 1999-10-01
TERMINATEDCommon conditions
Septic Shock5Hypertension4Adverse Effect3Hemodynamic Instability2Hypotension2Radiodermatitis2Shock2Anesthesia1Arrhythmia1Blood Pressure1Chronic Pulmonary Thromboembolism1Chronic Thromboembolic Pulmonary Hypertension (CTEPH)1Circulatory Shock1Diabetes Mellitus1Endotoxemia1Healthy1Hypertension, Pulmonary1Hypotension and Shock1Hypoxemic Respiratory Failure1Insulin Resistance1Ischemic Stroke1Nausea1Non-cardiac Surgery1Obesity1Pain1
Leading sponsors
General Hospital of Ningxia Medical University
5
Brigham and Women's Hospital
3
ProCertus BioPharm, Inc
2
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
2
University of Sao Paulo
2
Centre Hospitalier Universitaire Dijon
1
China National Center for Cardiovascular Diseases
1
Fondation Hôpital Saint-Joseph
1
Hospital Nossa Senhora da Conceicao
1
Peking Union Medical College Hospital
1
Pontificia Universidad Catolica de Chile
1
Radboud University Medical Center
1
Samsung Medical Center
1
Southeast University, China
1
University of Arkansas
1
Trial status mix
COMPLETED8
RECRUITING5
TERMINATED4
UNKNOWN4
WITHDRAWN3
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING2
SUSPENDED1
Phase mix
NA9
PHASE48
PHASE24
PHASE13
PHASE33
EARLY_PHASE12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.